(Q37516665)

20 August 2017

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting (English)

1 reference

20 August 2017

1

1 reference

20 August 2017

Bradley K Ackerson

2

1 reference

20 August 2017

Lina S Sy

3

1 reference

20 August 2017

Trung N Tran

4

1 reference

20 August 2017

Tonia L Jones

5

1 reference

20 August 2017

Janis F Yao

6

1 reference

20 August 2017

Fagen Xie

7

1 reference

20 August 2017

T Craig Cheetham

8

1 reference

20 August 2017

Patricia Saddier

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

9 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

27

1 reference

20 August 2017

34

1 reference

20 August 2017

4656-4661

1 reference

Uptake of varicella vaccination among young children in the United States: a success story in eliminating racial and ethnic disparities

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Societal impact of combination vaccines: experiences of physicians, nurses, and parents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Postmarketing evaluation of the safety and effectiveness of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.056

10.1016/J.VACCINE.2009.05.056

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference